Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Bennett

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|December 1, 1995
Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantationS M Katz, B Browne, T Phan, et al.
Neurobiology of Disease|June 20, 2022
Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarksA Muinos-Bühl, R Rombo, E Janzen, et al.
The American Journal of Pathology|May 5, 2001
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targetingM Mesri, M Morales-Ruiz, E J Ackermann, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in miceC F Bennett, D Kornbrust, S Henry, et al.
Anti-Cancer Drug Design|July 1, 1997
Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodentsD K Monteith, S P Henry, R B Howard, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivityS K Klimuk, S C Semple, P N Nahirney, et al.
The Journal of Biological Chemistry|May 2, 1997
2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cellsB F Baker, S S Lot, T P Condon, et al.
The Journal of Clinical Investigation|May 15, 1996
Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrateD S Grass, R H Felkner, M Y Chiang, et al.
Gastroenterology|June 3, 1998
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's diseaseB R Yacyshyn, M B Bowen-Yacyshyn, L Jewell, et al.
Journal of Drug Targeting|May 30, 1998
Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in cultureC F Bennett, D Mirejovsky, R M Crooke, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|December 1, 1995
Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantationS M Katz, B Browne, T Phan, et al.
Neurobiology of Disease|June 20, 2022
Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarksA Muinos-Bühl, R Rombo, E Janzen, et al.
The American Journal of Pathology|May 5, 2001
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targetingM Mesri, M Morales-Ruiz, E J Ackermann, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in miceC F Bennett, D Kornbrust, S Henry, et al.
Anti-Cancer Drug Design|July 1, 1997
Immune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodentsD K Monteith, S P Henry, R B Howard, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivityS K Klimuk, S C Semple, P N Nahirney, et al.
The Journal of Biological Chemistry|May 2, 1997
2'-O-(2-Methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cellsB F Baker, S S Lot, T P Condon, et al.
The Journal of Clinical Investigation|May 15, 1996
Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrateD S Grass, R H Felkner, M Y Chiang, et al.
Gastroenterology|June 3, 1998
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's diseaseB R Yacyshyn, M B Bowen-Yacyshyn, L Jewell, et al.
Journal of Drug Targeting|May 30, 1998
Structural requirements for cationic lipid mediated phosphorothioate oligonucleotides delivery to cells in cultureC F Bennett, D Mirejovsky, R M Crooke, et al.
Pageof 10